Milken Institute Statement on Newly Released FDA Guidance on Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Trials
Milken Institute Announces Tech Hub Partners Program to Link Business Leaders and Investors to Regional Tech Innovation Opportunities
Tech Regulation Digest: Regulating Direct-to-Consumer Drug Marketing in the US: FDA and FTC Adapt to Changing Tech Landscape
